Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Barelli

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neurobiology of Disease|February 15, 2000
Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profilesN Mestre-Francés, E Keller, A Calenda, et al.
Neurochemistry International|May 27, 2010
Further characterization of a neurotensin-degrading neutral metalloendopeptidase from rat brainH Barelli, F Girard, S St Pierrr, et al.
Peptides|May 1, 1993
Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosaH Barelli, Y K Mao, B Vincent, et al.
Biochemical and Biophysical Research Communications|April 20, 1999
S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidaseH Barelli, A Petit, E Hirsch, et al.
British Journal of Pharmacology|May 1, 1994
Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileumH Barelli, J E Fox-Threlkeld, V Dive, et al.
Peptides|September 1, 1989
Neuropeptide-hydrolysing activities in synaptosomal fractions from dog ileum myenteric, deep muscular and submucous plexi. Their participation in neurotensin inactivationH Barelli, S Ahmad, P Kostka, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's diseaseK Ancolio, C Dumanchin, H Barelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo studyH Barelli, Z Woskowska, S Cipris, et al.
Journal of Medicinal Chemistry|May 14, 1993
Synthesis and analgesic effects of N-[3-[(hydroxyamino) carbonyl]-1-oxo-2(R)-benzylpropyl]-L-isoleucyl-L-leucine, a new potent inhibitor of multiple neurotensin/neuromedin N degrading enzymesS Doulut, I Dubuc, M Rodriguez, et al.
European Journal of Biochemistry|July 15, 1987
Peptidases in dog-ileum circular and longitudinal smooth-muscle plasma membranes. Their relative contribution to the metabolism of neurotensinF Checler, S Ahmad, P Kostka, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neurobiology of Disease|February 15, 2000
Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profilesN Mestre-Francés, E Keller, A Calenda, et al.
Neurochemistry International|May 27, 2010
Further characterization of a neurotensin-degrading neutral metalloendopeptidase from rat brainH Barelli, F Girard, S St Pierrr, et al.
Peptides|May 1, 1993
Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosaH Barelli, Y K Mao, B Vincent, et al.
Biochemical and Biophysical Research Communications|April 20, 1999
S 17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidaseH Barelli, A Petit, E Hirsch, et al.
British Journal of Pharmacology|May 1, 1994
Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileumH Barelli, J E Fox-Threlkeld, V Dive, et al.
Peptides|September 1, 1989
Neuropeptide-hydrolysing activities in synaptosomal fractions from dog ileum myenteric, deep muscular and submucous plexi. Their participation in neurotensin inactivationH Barelli, S Ahmad, P Kostka, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's diseaseK Ancolio, C Dumanchin, H Barelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo studyH Barelli, Z Woskowska, S Cipris, et al.
Journal of Medicinal Chemistry|May 14, 1993
Synthesis and analgesic effects of N-[3-[(hydroxyamino) carbonyl]-1-oxo-2(R)-benzylpropyl]-L-isoleucyl-L-leucine, a new potent inhibitor of multiple neurotensin/neuromedin N degrading enzymesS Doulut, I Dubuc, M Rodriguez, et al.
European Journal of Biochemistry|July 15, 1987
Peptidases in dog-ileum circular and longitudinal smooth-muscle plasma membranes. Their relative contribution to the metabolism of neurotensinF Checler, S Ahmad, P Kostka, et al.
Pageof 3